Cargando…
Inducing multiple antibodies to treat squamous cell esophageal carcinoma
BACKGROUND: The positive response and the clinical usefulness of 14 serum antibodies in patients with esophageal squamous cell carcinoma (ESCC) were examined in this study. The Cancer Genome Atlas (TCGA) was used to investigate the frequency of gene expressions, mutations, and amplification of these...
Autores principales: | Hoshino, Isamu, Nabeya, Yoshihiro, Takiguchi, Nobuhiro, Gunji, Hisashi, Ishige, Fumitaka, Iwatate, Yosuke, Kuwajima, Akiko, Shiratori, Fumiaki, Okada, Rei, Shimada, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568359/ https://www.ncbi.nlm.nih.gov/pubmed/33069225 http://dx.doi.org/10.1186/s12885-020-07466-0 |
Ejemplares similares
-
Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers
por: Hoshino, Isamu, et al.
Publicado: (2020) -
Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020) -
A case of Barrett’s esophageal cancer with gastric mucosa-associated lymphoma
por: Shiratori, Fumiaki, et al.
Publicado: (2020) -
Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2021) -
Surgical treatment strategy for esophagogastric junction cancers based on the tumor diameter
por: Hoshino, Isamu, et al.
Publicado: (2019)